文献速递物质与行为成瘾心境障碍精神分裂症与精神病性障碍

重性精神障碍、物质使用行为与长寿

Major Psychiatric Disorders, Substance Use Behaviors, and Longevity.
PubMed 文献 · JAMA Psychiatry · 2024-01-01

本双样本孟德尔随机化研究评估重性精神障碍与物质使用行为(吸烟、饮酒)的遗传易感性与长寿的关联,发现吸烟的遗传易感性与长寿呈负相关,而精神障碍的遗传易感性未显示关联;转录组学分析提示吸烟相关通路,并识别出潜在蛋白质组学治疗靶点。

要点

  • 在多种精神障碍与物质使用行为同时评估的多变量孟德尔随机化模型中,吸烟与长寿呈负相关(β=-0.33)。
  • 吸烟与表观遗传年龄加速增加相关(例如PhenoAge:β=1.76)。
  • 转录组归因和共定位分析识别出249个与吸烟相关的基因,其中36个为原吸烟GWAS未捕获的新基因。

核心结论

  • 研究结果提示,吸烟的遗传易感性而非精神障碍的遗传易感性与长寿相关。
  • 转录组学关联为吸烟相关通路提供了见解,识别出的蛋白质组学靶点可能为戒烟策略的治疗开发提供信息。

研究设计与样本

  • 本研究为双样本孟德尔随机化研究,使用单变量和多变量模型评估精神障碍、物质使用行为与长寿的关联。
  • 研究进行了多组学分析以阐明孟德尔随机化关联的转录组学基础并识别潜在蛋白质组学治疗靶点。
  • 研究数据来源为欧洲血统队列的汇总水平全基因组关联研究数据、基因表达和蛋白质组学数据。
  • 分析于2022年5月至2023年11月进行。
  • 暴露包括重性抑郁(n=500199)、双相障碍(n=413466)、精神分裂症(n=127906)、问题性饮酒(n=435563)、每周酒精消费量(n=666978)和终生吸烟指数(n=462690)的遗传易感性。

主要发现

  • 在多变量孟德尔随机化模型中同时评估精神障碍和物质使用行为,欧洲血统队列(n=709709;431503[60.8%]女性)中吸烟与长寿呈负相关(β=-0.33;95%CI,-0.38至-0.28;P=4.59×10-34)。
  • 吸烟与表观遗传年龄加速增加相关(n=34449;18017[52.3%]女性;例如PhenoAge:β=1.76;95%CI,0.72至2.79;P=8.83×10-4)。
  • 转录组归因和共定位分析识别出249个与吸烟相关的基因,包括36个原吸烟GWAS未捕获的新基因。
  • 富集通路包括染色质重塑和端粒组装与维护。
  • 吸烟的转录组范围特征与长寿呈负相关,个体吸烟相关基因(如XRCC3和PRMT6)的估计与吸烟-长寿孟德尔随机化分析一致,提示潜在的转录组中介。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Observational studies suggest that major psychiatric disorders and substance use behaviors reduce longevity, making it difficult to disentangle their relationships with aging-related outcomes. OBJECTIVE: To evaluate the associations between the genetic liabilities for major psychiatric disorders, substance use behaviors (smoking and alcohol consumption), and longevity. DESIGN, SETTINGS, AND PARTICIPANTS: This 2-sample mendelian randomization (MR) study assessed associations between psychiatric disorders, substance use behaviors, and longevity using single-variable and multivariable models. Multiomics analyses were performed elucidating transcriptomic underpinnings of the MR associations and identifying potential proteomic therapeutic targets. This study sourced summary-level genome-wide association study (GWAS) data, gene expression, and proteomic data from cohorts of European ancestry. Analyses were performed from May 2022 to November 2023. EXPOSURES: Genetic susceptibility for major depression (n = 500 199), bipolar disorder (n = 413 466), schizophrenia (n = 127 906), problematic alcohol use (n = 435 563), weekly alcohol consumption (n = 666 978), and lifetime smoking index (n = 462 690). MAIN OUTCOMES AND MEASURES: The main outcome encompassed aspects of health span, lifespan, and exceptional longevity. Additional outcomes were epigenetic age acceleration (EAA) clocks. RESULTS: Findings from multivariable MR models simultaneously assessing psychiatric disorders and substance use behaviorsm suggest a negative association between smoking and longevity in cohorts of European ancestry (n = 709 709; 431 503 [60.8%] female; β, -0.33; 95% CI, -0.38 to -0.28; P = 4.59 × 10-34) and with increased EAA (n = 34 449; 18 017 [52.3%] female; eg, PhenoAge: β, 1.76; 95% CI, 0.72 to 2.79; P = 8.83 × 10-4). Transcriptomic imputation and colocalization identified 249 genes associated with smoking, including 36 novel genes not captured by the original smoking GWAS. Enriched pathways included chromatin remodeling and telomere assembly and maintenance. The transcriptome-wide signature of smoking was inversely associated with longevity, and estimates of individual smoking-associated genes, eg, XRCC3 and PRMT6, aligned with the smoking-longevity MR analyses, suggesting underlying transcriptomic mediators. Cis-instrument MR prioritized brain proteins associated with smoking behavior, including LY6H (β, 0.02; 95% CI, 0.01 to 0.03; P = 2.37 × 10-6) and RIT2 (β, 0.02; 95% CI, 0.01 to 0.03; P = 1.05 × 10-5), which had favorable adverse-effect profiles across 367 traits evaluated in phenome-wide MR. CONCLUSIONS: The findings suggest that the genetic liability of smoking, but not of psychiatric disorders, is associated with longevity. Transcriptomic associations offer insights into smoking-related pathways, and identified proteomic targets may inform therapeutic development for smoking cessation strategies.

来源:JAMA Psychiatry,查看原文。版权归原作者所有。

引用

  1. Rosoff DB, Hamandi AM, Bell AS, et al. Major Psychiatric Disorders, Substance Use Behaviors, and Longevity. JAMA Psychiatry. 2024. PMID: 38888899. doi:10.1001/jamapsychiatry.2024.1429

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。